Drug Approval | October 06, 2025
Investment to expand manufacturing and global medicine supply capacity
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Merck opens first climate-neutral manufacturing facility in Ireland
The FDA is beginning rulemaking to close the “adequate provision” loophole
Brenntag Specialties will provide pharmaceutical manufacturers and biopharmaceutical companies with a reliable supply of high-purity, GMP-compliant acetates
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Subscribe To Our Newsletter & Stay Updated
